ESSL - European Severe Storms Laboratory
Is damaging hail getting worse?
plus
Actualités de Austria
- Langue:
- Médias:
- Période:
- Période:Totale
Croma-Pharma GmbH Announces Strategic Milestone as Novaestiq Corp. Joins Waldencast
Leobendorf, Austria (ots/PRNewswire) - Saypha® injectables to launch in the U.S. under the Obagi Medical brand, expanding global reach of Croma's science-driven aesthetic solutions Croma-Pharma GmbH, a global leader in minimally invasive aesthetic medicine, today announced the acquisition of Novaestiq Corp. by Waldencast plc (Nasdaq: WALD). Novaestiq, a joint venture ...
plusams OSRAM and LEDVANCE extend global brand partnership into the next decade
plusNext-generation GaN e-mobility technology; KYOCERA AVX Salzburg and VisIC Technologies expand their collaboration
Ness Ziona, Israel and Salzburg, Austria (ots/PRNewswire) - Combining KYOCERA AVX's leadership in discrete and module packaging along with VisIC's expertise in GaN power devices to offer cutting-edge products, including the highest efficiency power module for lead EV OEM and Tier 1 traction inverters. VisIC ...
plusEV Group and Teramount Announce Collaboration to Implement Innovative Packaging Technologies for Photonic Integrated Circuits
ST. Florian, Austria and Jerusalem (ots/PRNewswire) - Breakthrough wafer-level optics technologies help solve a key challenge of connecting many fibers to silicon chips for datacom and telecom applications EV Group (EVG), a leading supplier of wafer bonding and lithography equipment for the MEMS, nanotechnology and ...
plusSeibersdorf Labor GmbH; Isotopia Molecular Imaging
Isotopia Molecular Imaging and Seibersdorf Labor GmbH Announce Production Agreement for 177Lu n.c.a.
Tel Aviv, Israel and Vienna, Austria (ots/PRNewswire) - Isotopia Molecular Imaging and Seibersdorf Labor are pleased to announce that they have entered into an agreement for the production of no-carrier-added Lutetium-177, a critical medical radioisotope used in the manufacturing of radiopharmaceuticals for ...
plus
RS and Mosdorfer Announce Distribution Agreement
Calgary, Alberta And Weiz, Austria (ots/PRNewswire) - RS Technologies Inc. ("RS") and Mosdorfer GmbH, Mosdorfer CCL Systems Ltd. and EA Elektroarmaturen (collectively "Mosdorfer") are pleased to announce a new distribution agreement whereby Mosdorfer will act as an authorized, exclusive distributor of RS's composite utility poles to utility customers in the United Kingdom, certain European countries (including Austria, ...
plusSanofi Announces Upcoming Launch of MyStar Connect®
Vienna, Austria (ots) - - MyStar Connect® software contributes to Sanofi's commitment in providing integrated diabetes care solutions, and supports healthcare professionals in clinical decision-making - - CE mark for MyStar Connect® - At the 50th annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria, Sanofi (EURONEXT: SAN and NYSE: SNY) announced today the upcoming launch of ...
plusE-com payment system by lov!it covers all in one
Goetzis, Austria (ots) - Lov!it - a unique reversed market platform for e- commerce shops and blogs - is now offering also credit card, direct debit and PayPal payments. With these new products Lov!it continues its internationalisation strategy. Lov!it now offers all important payment options and is able to substitute old fashioned payment service providers. Additional services are dunning, taxation in over 15 countries ...
plusOral Palonosetron shows safe and effective control of nausea and vomiting induced by multiple cycles of chemotherapy
Lugano, Switzerland & Vienna, Austria (ots) - New data presented at the 2012 meeting of the European Society of Medical Oncology (ESMO) in Vienna show antiemetic efficacy maintained across the chemotherapy cycles and a positive safety profile The oral formulation of palonosetron, the second generation 5-HT3 receptor ...
plusEisai Presents new Research for Investigational Compound Lenvatinib at the European Society for Medical Oncology
Vienna, Austria (ots/PRNewswire) - INTENDED FOR EUROPEAN MEDIA ONLY Results from a Phase I/II trial of the investigational compound lenvatinib (E7080), a multi-targeted, kinase inhibitor, in people with advanced hepatocellular cancer have been presented at the ESMO 2012 Congress (European Society for Medical ...
plus
1